Vertex Pharmaceuticals Incorporated - Common Stock - Nakit Akışı (NASDAQ:VRTX)

Financials

İşletme faaliyetlerinden elde edilen nakit 3.25 B2.64 B4.13 B3.54 B-492.6 M3.63 B 4.24 B Yatırım faaliyetlerinden elde edilen nakit 99.39 M-340.9 M-321.1 M-3.14 B-3.77 B-945.4 M -1.32 B Finansman faaliyetlerinden elde edilen nakit -505.28 M-1.48 B-67.7 M-562.2 M-1.49 B-2.26 B -2.12 B Serbest nakit akışı 3.25 B2.64 B4.13 B3.54 B-492.6 M3.63 B 4.24 B

Vertex Pharmaceuticals Incorporated - Common Stock

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

VRTX

Financials

Vertex Pharmaceuticals Incorporated - Common Stock

Haberler

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Truist, Vertex hissesi için böbrek ilaçları nedeniyle al önerisiyle kapsama başladı

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

These Are The Upcoming Catalysts For Crispr Therapeutics Stock (NASDAQ:CRSP)

What Are Wall Street Analysts' Target Price for Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals Incorporated (VRTX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex Pharmaceuticals hisseleri neden yükselişte?

VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings

Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review

BMO Capital, Vertex için 17 dolarlık hedef fiyatı korudu